Aevi Genomic Med

GNMX NASDAQ
0.2029
-0.0159
-7.29%
After Hours: 0.2000 -0.0029 -1.43% 17:35 07/17 EDT
Open
0.2015
Prev Close
0.2188
High
0.2100
Low
0.1900
Volume
1.74M
Avg Vol (3M)
1.29M
52 Week High
1.400
52 Week Low
0.1500
% Turnover
2.69%
Market Cap
13.14M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Aevi Genomic Med GNMX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The Company's product candidates include AEVI-001 and AEVI-002. The Company's research and development efforts leverage an internal genomics platform and a collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). .
MORE >

Recently

Name
Price
%Change